HCWB HCW Biologics Inc
Company Analysis
Latest News
🔴 HCWB is trading 8% down today on profit-taking after a 129% regular-session surge
HCWB is trading about 8% down in after-hours at $2.18 as traders lock in profits following a massive 129.25% regular-session surge to $2.43. • The reversal...
🔴 HCWB is trading 8% down today on profit-taking after massive 129% surge
HCWB is trading at $2.23, down 8% in after-hours action as the stock eases off a 129.25% surge recorded during the prior regular session. • The pullback...
🔴 HCWB is trading 6% down today amid speculative volatility following recent momentum-driven surges
HCWB is trading about 6% down in after-hours at $2.29 as the stock eases back from a 129.25% surge amid extreme speculative volatility. • There are no fresh...
🟢 HCWB is trading 20.8% up today as it rebounds from recent volatility
HCWB is trading at $1.28 (+20.8%), rebounding sharply as speculative trading continues following extreme price swings in recent sessions. • The stock is...
🔴 HCWB is trading 5.7% down today as it eases back after recent extreme volatility
HCWB is trading 5.7% down today at $1.00 in pre-market as it continues to digest recent speculative gains and extreme price volatility. • The stock is pulling...
HCW Biologics Inc Q1 2026 Earnings Preview: What Analysts Expect on May 21, 2026
As HCW Biologics prepares for its Q1 2026 earnings call, analysts are modeling a consensus net loss of $0.44 per share on zero core revenue, with the stock...
HCW Biologics' One-Time Licensing Windfall Fades Fast — Can a Company With $1.2M in Cash Survive What Comes Next?
Shares of HCW Biologics slid 16% to $1.12 on May 19, after a blistering rally that had tripled the stock from $0.34 to $1.34 in a single session last week. The...
🔴 HCWB is trading 16% down today as profit-taking follows a one-time licensing-driven spike
HCWB is trading at $1.12 (16.0% down) as traders lock in profits following a recent surge triggered by a one-time $6.5 million licensing payment. • The $6.5...
🟢 HCWB is trading 6.6% up today on rare Q1 swing to profitability via $6.5M licensing deal
HCWB is trading 6.6% up today at $1.30 after swinging to a rare Q1 profitability driven by a $6.5 million licensing deal with Beijing Trimmune Biotech. • The...
HCW Biologics Extends Massive Rally After Licensing Deal Drives Q1 Profit
HCW Biologics shares rose 8.20% to $1.32 following a Q1 2026 report showing a swing to a $3.47 million net income. The surge is primarily attributed to a $6.5...